αB-crystallin (F-10): sc-137129. Western blot analysis of αB-crystallin expression in non-transfected: sc-117752 (A) and mouse αB-crystallin transfected: sc-118149 (B) 293T whole cell lysates.
αB-crystallin (F-10): sc-137129. Western blot analysis of αB-crystallin expression in non-transfected 293T: sc-117752 (A), human αB-crystallin transfected 293T: sc-159467 (B) and Y79 (C) whole cell lysates.
αB-crystallin (F-10): sc-137129. Western blot analysis of αB-crystallin expression in non-transfected 293T: sc-117752 (A), human αB-crystallin transfected 293T: sc-159351 (B) and Y79 (C) whole cell lysates.
αB-crystallin (F-10): sc-137129. Western blot analysis of αB-crystallin expression in non-transfected 293: sc-110760 (A), human αB-crystallin transfected 293: sc-127880 (B) and Y79 (C) whole cell lysates.
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) rat heart tissue extract. Antibodies tested include p-αB-crystallin (hSer 59)-R: sc-22509-R (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) rat kidney tissue extract. Antibodies tested include p-αB-crystallin (hSer 59)-R: sc-22509-R (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) rat heart tissue extract. Antibodies tested include p-αB-crystallin (mSer 59)-R: sc-22510-R (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) rat kidney tissue extract. Antibodies tested include p-αB-crystallin (mSer 59)-R: sc-22510-R (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) rat heart tissue extracts. Antibodies tested include p-αB-crystallin (hSer 59)-R: sc-22509-R (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) human heart tissue extracts. Antibodies tested include p-αB-crystallin (hSer 59)-R: sc-22509-R (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) rat kidney tissue extracts. Antibodies tested include p-αB-crystallin (F-1): sc-365884 (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) rat heart tissue extracts. Antibodies tested include p-αB-crystallin (F-1): sc-365884 (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
Western blot analysis of αB-crystallin phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) human heart tissue extracts. Antibodies tested include p-αB-crystallin (F-1): sc-365884 (A,B) and αB-crystallin (F-10): sc-137129 (C,D).
αB-crystallin (F-10): sc-137129. Western blot analysis of αB-crystallin expression in mouse heart tissue extract.